Free Trial

AMNEAL PHARMACEUTICALS (AMRX) Competitors

AMNEAL PHARMACEUTICALS logo
$10.36 -0.08 (-0.72%)
As of 12:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AMRX vs. RDY, VTRS, ROIV, BBIO, MRNA, QGEN, ELAN, VRNA, RVMD, and ABVX

Should you be buying AMNEAL PHARMACEUTICALS stock or one of its competitors? The main competitors of AMNEAL PHARMACEUTICALS include Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), BridgeBio Pharma (BBIO), Moderna (MRNA), QIAGEN (QGEN), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), and Abivax (ABVX). These companies are all part of the "pharmaceutical products" industry.

AMNEAL PHARMACEUTICALS vs. Its Competitors

AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

In the previous week, AMNEAL PHARMACEUTICALS had 1 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 2 mentions for AMNEAL PHARMACEUTICALS and 1 mentions for Dr. Reddy's Laboratories. Dr. Reddy's Laboratories' average media sentiment score of 1.78 beat AMNEAL PHARMACEUTICALS's score of 0.54 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMNEAL PHARMACEUTICALS
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Dr. Reddy's Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Dr. Reddy's Laboratories has a net margin of 16.99% compared to AMNEAL PHARMACEUTICALS's net margin of 0.12%. Dr. Reddy's Laboratories' return on equity of 17.25% beat AMNEAL PHARMACEUTICALS's return on equity.

Company Net Margins Return on Equity Return on Assets
AMNEAL PHARMACEUTICALS0.12% -189.49% 6.17%
Dr. Reddy's Laboratories 16.99%17.25%11.63%

AMNEAL PHARMACEUTICALS has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.

AMNEAL PHARMACEUTICALS presently has a consensus target price of $12.00, suggesting a potential upside of 15.89%. Dr. Reddy's Laboratories has a consensus target price of $16.95, suggesting a potential upside of 16.06%. Given Dr. Reddy's Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Dr. Reddy's Laboratories is more favorable than AMNEAL PHARMACEUTICALS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMNEAL PHARMACEUTICALS
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Dr. Reddy's Laboratories
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83

31.8% of AMNEAL PHARMACEUTICALS shares are held by institutional investors. Comparatively, 3.9% of Dr. Reddy's Laboratories shares are held by institutional investors. 26.6% of AMNEAL PHARMACEUTICALS shares are held by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Dr. Reddy's Laboratories has higher revenue and earnings than AMNEAL PHARMACEUTICALS. Dr. Reddy's Laboratories is trading at a lower price-to-earnings ratio than AMNEAL PHARMACEUTICALS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMNEAL PHARMACEUTICALS$2.79B1.16-$116.89M$0.011,035.50
Dr. Reddy's Laboratories$3.81B3.20$663M$0.6622.13

Summary

Dr. Reddy's Laboratories beats AMNEAL PHARMACEUTICALS on 11 of the 17 factors compared between the two stocks.

Get AMNEAL PHARMACEUTICALS News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMRX vs. The Competition

MetricAMNEAL PHARMACEUTICALSMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.25B$2.62B$6.16B$10.65B
Dividend YieldN/A57.76%5.72%4.86%
P/E Ratio1,036.5423.6729.5728.20
Price / Sales1.16777.64573.64128.09
Price / Cash7.41170.4137.1261.42
Price / Book-29.595.3412.226.50
Net Income-$116.89M$33.06M$3.32B$276.73M
7 Day Performance4.91%-0.48%-0.50%-0.16%
1 Month Performance5.23%5.83%5.68%1.37%
1 Year Performance24.46%-3.06%68.21%32.60%

AMNEAL PHARMACEUTICALS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMRX
AMNEAL PHARMACEUTICALS
2.5527 of 5 stars
$10.36
-0.7%
$12.00
+15.9%
+22.7%$3.25B$2.79B1,036.548,100
RDY
Dr. Reddy's Laboratories
2.9368 of 5 stars
$14.36
+0.1%
$16.95
+18.1%
-6.7%$11.97B$3.81B21.7527,811
VTRS
Viatris
3.0501 of 5 stars
$9.86
+1.2%
$10.40
+5.5%
-10.8%$11.36B$14.74B-3.4032,000Analyst Forecast
ROIV
Roivant Sciences
2.8895 of 5 stars
$16.21
+1.1%
$19.94
+23.0%
+53.1%$10.95B$29.05M-23.16860
BBIO
BridgeBio Pharma
4.5827 of 5 stars
$55.96
+0.8%
$63.94
+14.3%
+113.5%$10.61B$221.90M-13.68400Analyst Forecast
MRNA
Moderna
4.2622 of 5 stars
$26.74
-0.3%
$41.81
+56.4%
-49.7%$10.48B$3.24B-3.555,800Trending News
Analyst Forecast
Gap Down
QGEN
QIAGEN
4.1454 of 5 stars
$47.30
+1.0%
$49.40
+4.4%
+18.4%$10.41B$1.98B27.955,765Positive News
ELAN
Elanco Animal Health
2.7271 of 5 stars
$20.04
+1.4%
$19.14
-4.5%
+70.9%$9.82B$4.44B23.309,000Analyst Forecast
VRNA
Verona Pharma PLC American Depositary Share
1.0772 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.3018 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+12.4%$9.02B$11.58M-10.83250News Coverage
Analyst Upgrade
ABVX
Abivax
3.4727 of 5 stars
$95.63
+2.0%
$114.25
+19.5%
+763.9%$7.30BN/A0.0061Short Interest ↓

Related Companies and Tools


This page (NASDAQ:AMRX) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners